Dr. Patrick Reynolds, M.D. Ph. D.
BA in Biology from The University of Texas at Austin
MD from UT Southwestern Medical School in Dallas, TX
PhD (Cell Biology) from UT Austin
Pediatrics training at the National Naval Medical Center Bethesda, MD
Postdoctoral fellowship was in cancer immunology at UT Southwestern Medical School, Dallas, TX
- Alternative lengthening of telomeres (ALT) in cancer as a biomarkers and therapeutic targets
- Mechanisms of drug resistance and drugs to modulate resistance in childhood and adult cancers
- Development of novel preclinical testing models for cancer drug development
- Clinical trials testing novel therapeutic approaches for cancer
Dr. Reynolds is the Cancer Center Director for the School of Medicine, Texas Tech University Health Sciences Center (TTUHSC), and is Director of the South Plains Oncology Consortium (SPOC). He is a Professor of Pediatrics, Cell Biology & Biochemistry, and Medicine at the TTUHSC School of Medicine.
Dr. Reynolds is a member of the neuroblastoma steering committee for the Children's Oncology Group. He has served on multiple grant review study sections and steering committees for the National Cancer Institute. He is a member of the Advisory Committee for Childhood Cancer and the Clinical Trials Advisory Committee for the Cancer Prevention & Research Institute of Texas (CPRIT).
Dr. Reynolds sponsors multiple FDA Investigational New Drug (IND) applications and has active grant support from the National Cancer Institute (NCI), the Department of Defense, and the Cancer Prevention & Research Institute of Texas, and Alex's Lemonade Stand Foundation. His laboratory serves as the Childhood Cancer Repository for the Children's Oncology Group, powered by Alex's Lemonade Stand Foundation. Dr. Reynolds is an author or co-author of more than 250 peer-reviewed scientific papers that have garnered > 30,000 citations.